Eterna Therapeutics Inc
NASDAQ:ERNA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Eterna Therapeutics Inc
NASDAQ:ERNA
|
US |
|
Entrada Therapeutics Inc
NASDAQ:TRDA
|
US |
|
R
|
RomReal Ltd
F:3RR
|
BM |
|
Aegis Brands Inc
OTC:SCUPF
|
CA |
|
Z
|
Zacatecas Silver Corp
F:7TV
|
CA |
|
Trigano SA
PAR:TRI
|
FR |
|
A
|
Allwyn AG
XMUN:GF8
|
LU |
|
Blackbaud Inc
NASDAQ:BLKB
|
US |
|
Damora Therapeutics Inc
NASDAQ:DMRA
|
US |
|
C
|
Chenab Ltd
KAR:CHBL
|
PK |
|
Western Resources Corp
F:WR0
|
CA |
|
C
|
Chunghwa Precision Test Tech Co Ltd
TPEX:6510
|
TW |
|
P
|
PVA TePla AG
F:TPE
|
DE |
|
A
|
Axel REE Ltd
ASX:AXL
|
AU |
|
M
|
Matahari Putra Prima Tbk PT
XMUN:LU6A
|
ID |
Bankruptcy Probability
Eterna Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Eterna Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Eterna Therapeutics Inc
NASDAQ:ERNA
|
2.6m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
479.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
223.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
182.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
128.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
76.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
78.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
87.2B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
52.4B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
56.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
43B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Eterna Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Eterna Therapeutics Inc has no debt.
You can find a full breakdown on its Balance Sheet.